Fingerprint
Dive into the research topics of 'Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
Shashi Gujar, Jonathan G. Pol, Youra Kim, Guido Kroemer
Research output: Contribution to journal › Review article › peer-review
10
Citations
(Scopus)